EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Basal Ganglia Atrophy as a Marker for Prodromal X‐Linked Dystonia‐Parkinsonism

Henrike Hanssen iD, Cid C E Diesta, Marcus Heldmann, Jackson Dy, Jeffrey Tantianpact, Julia Steinhardt, Rosanna Sauza, Hans T S Manalo, Andreas Sprenger, Charles Jourdan Reyes, Raphael Tuazon, Björn-Hergen Laabs und 7 weitere

Annals of Neurology · 2023-05 · 93 (5) · 999-1011

DOI: 10.1002/ana.26606 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Neurology, online erschienen am 17.02.2023. Verfasst von Henrike Hanssen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Schleswig-Holstein, Lübeck, Germany. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Dystonic Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In neurodegenerative diseases, the characterization of the prodromal phase is essential for the future application of disease‐modifying therapies. X‐linked dystonia‐parkinsonism is a hereditary neurodegenerative movement disorder characterized by severe adult‐onset dystonia accompanied by parkinsonism. Distinct striatal and pallidal atrophy is present already in early disease stages indicating a long‐lasting presymptomatic degenerative process. To gain insight into the prodromal phase of X‐linked dystonia‐parkinsonism, structural and iron‐sensitive magnetic resonance imaging (MRI) was performed in 10 non‐manifesting carriers and 24 healthy controls in a double‐blind fashion. Seventeen patients with X‐linked dystonia‐parkinsonism were recruited to replicate previous findings of basal ganglia pathology and iron accumulation. Age at onset was estimated in non‐manifesting carriers and patients using the repeat length of the hexanucleotide expansion and 3 single‐nucleotide polymorphisms associated with age at onset. Voxel‐based morphometry and subcortical volumetry showed striatal and pallidal atrophy in non‐manifesting carriers (~10%) and patients (~40%). Substantia nigra volume was similarly reduced in patients (~40%). Caudate volume correlated with time to estimated onset in non‐manifesting carriers. Susceptibility‐weighted imaging confirmed iron deposition in the anteromedial putamen in patients. Non‐manifesting carriers also showed small clusters of iron accumulation in the same area after lowering the statistical threshold. In conclusion, basal ganglia atrophy and iron accumulation precede the clinical onset of X‐linked dystonia‐parkinsonism and can be detected years before the estimated disease manifestation. It thereby highlights the potential of multimodal imaging to identify clinically unaffected mutation carriers with incipient neurodegeneration and to monitor disease progression independent of clinical measures. Longitudinal studies are needed to further elucidate the onset and progression rate of neurodegeneration in prodromal X‐linked dystonia‐parkinsonism. ANN NEUROL 2023;93:999–1011

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesDystonic DisordersGenetic Diseases, X-LinkedAdultAtrophyParkinson DiseaseBasal GangliaIronHumansMagnetic Resonance Imaging

Substanzen

Iron

Autor:innen und Institutionen

  • Department of Neurology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Department of Neuroscience, Makati Medical Center, Makati City, Philippines.
  • Department of Neuroscience, Asian Hospital and Medical Center, Manila, Philippines.
  • Institute of Psychology II, University of Lübeck, Lübeck, Germany.
  • Department of Radiology, Makati Medical Center, Makati City, Philippines.

ORCID-Profile: Henrike Hanssen, Christine Klein, Ana Westenberger, Norbert Brüggemann

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Hanssen, H., Diesta, C. C. E., Heldmann, M., Dy, J., Tantianpact, J., Steinhardt, J., Sauza, R., Manalo, H. T. S., Sprenger, A., Reyes, C. J., Tuazon, R., Laabs, B. H., Domingo, A., Rosales, R. L., Klein, C., Münte, T. F., Westenberger, A., Oropilla, J. Q., & Brüggemann, N. (2023). Basal Ganglia Atrophy as a Marker for Prodromal X‐Linked Dystonia‐Parkinsonism. Annals of Neurology, 93(5), 999-1011. https://doi.org/10.1002/ana.26606

Vancouver

Hanssen H, Diesta CCE, Heldmann M, Dy J, Tantianpact J, Steinhardt J, et al. Basal Ganglia Atrophy as a Marker for Prodromal X‐Linked Dystonia‐Parkinsonism. Annals of Neurology. 2023;93(5):999-1011. doi:10.1002/ana.26606

BibTeX
@article{Hanssen2023,
  author = {Hanssen, Henrike and Diesta, Cid C E and Heldmann, Marcus and Dy, Jackson and Tantianpact, Jeffrey and Steinhardt, Julia and Sauza, Rosanna and Manalo, Hans T S and Sprenger, Andreas and Reyes, Charles Jourdan and Tuazon, Raphael and Laabs, Björn-Hergen and Domingo, Aloysius and Rosales, Raymond L and Klein, Christine and Münte, Thomas F and Westenberger, Ana and Oropilla, Jean Q and Brüggemann, Norbert},
  title = {Basal Ganglia Atrophy as a Marker for Prodromal X‐Linked Dystonia‐Parkinsonism},
  journal = {Annals of Neurology},
  year = {2023},
  volume = {93},
  number = {5},
  pages = {999--1011},
  doi = {10.1002/ana.26606}
}
Kostenlos starten →